Treatment of neonatal seizures with carbamazepine

Journal of Child Neurology

Volumn 11, Issue 5, 1996, Pages 378-382

  Singh, Balbir ^a   Singh, Poonam ^b   Al Hifzi, Ibrahim ^b   Khan, Masood ^b   Majeed Saidan, Mohammed ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

ANTICONVULSANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; HUMAN; INTRAGASTRIC DRUG ADMINISTRATION; NEWBORN; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

EID: 0029832762     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389601100506     Document Type: Article

References (16)

1. Lockman LA, Kriel R, Zaske D, et al: Phenobarbital dosage for control of neonatal seizures. Neurology 1979;29:1445-1449.
2. Vanorman CB, Darivish HA: Efficacy of phenobarbitone in neonatal seizures. Can J Neurol Sci 1985;12:95-99.
3. Painter MJ, Pippenger C, Wasterlain CG, et al: Phenobarbital and phenytoin in neonatal seizures: Metabolism and tissue distribution. Neurology 1981;31:1107-1112.
4. Albani M: Phenytoin in infancy and childhood, in Delgado-Escueta AV, Wasterlain CG, Trierman DM, Porter RJ (eds): Advances in Neurology: Status Epilepticus. New York, Raven Press, 1983, pp 457-464.
5. Diaz J, Schain RJ, Bailey BG: Phenobarbital induced brain growth retardation in artificially reared rat pups. Biol Neonate 1977; 32:77-32.
6. Daval J-L, Pereira de Vasconcelos A, Lartaud I: Development of mammalian cultured neurons following exposure to anticonvulsant drugs, in Wasterlain CG, Vert P (eds): Neonatal Seizures. New York, Raven Press, 1990, pp 295-301.
7. Mattson RH, Cramer JA, Collins JF, et al: Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic clonic seizures. N Engl J Med 1985;313:145-151.
8. Ramsay RE, Wilder BJ, Berger JR, Bruni J: A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology 1983;33:904-910.
9. Mizrahi EM, Kellaway P: Characterization and classification of neonatal seizures. Neurology 1987;37:1837-1844.
10. Miles MV, Lawless ST, Tennison MB, et al: Rapid loading of critically ill patients with carbamazepine suspension. Pediatrics 1990; 86:263-266.
11. MacKintosh DA, Baird-Lampert J, Buchanan N: Is carbamazepine an alternative maintenance therapy for neonatal seizures? Dev Pharmacol Ther 1987;10:100-106.
12. Kuhnz W, Jager-Roman E, Rating D, et al: Carbamazepine and carbamazepine-10,11-epoxide during pregnancy and postnatal period in epileptic mothers and their nursed infants, pharmacokinetics and clinical effects. Pediatr Pharmacol 1983;3:199-208.
13. Rane A, Bertilsson L, Palmer L: Disposition of placentally transferred carbamazepine (Tegretol) in the newborn. Eur J Clin Pharmacol 1975;8:283-284.
14. Rey E, d'Athis P, De Lauture D, et al: Pharmacokinetics of carbamazepine in the neonate and in the child. Int J Clin Pharmacol Biopharm 1979;17:90-96.
15. Eichelbaum M, Ekbom K, Bertilsson L, et al: Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Eur J Clin Pharmacol 1975;8:337-341.
16. Andre M, Vert P, Wasterlain CG: To treat or not to treat: A survey of current medical practice toward neonatal seizures, in Wasterlain CG, Vert P (eds): Neonatal Seizures. New York, Raven Press, 1990, pp 303-307.